Form 4: Anna U. Loengard Increases Stake in Clover Health Investments, Corp. (CLOV)

Director Anna U. Loengard reports purchasing 137,000 shares of Clover Health Investments, Corp. at an average price of $0.73 per share.

Summary

• On March 14, 2024, Anna U. Loengard, a director of Clover Health Investments, Corp., purchased 137,000 shares of Class A Common Stock at a price of $0.73 per share.
• This transaction increased her direct holdings to 538,841 shares.
• She also has indirect ownership through a spouse's IRA (10,000 shares), a son's custodial account (1,300 shares), and a daughter's custodial account (15,125 shares).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the purchase indicates confidence from a director, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely watched by investors as they can provide insights into a company's performance and future prospects. A director's purchase is generally viewed more positively than a sale.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates